Preliminary comparative outcomes of Versius Robotic System-assisted cholecystectomy and laparoscopic cholecystectomy for benign gall bladder disease: Retrospective single-centre, single-surgeon analysis

机器人辅助胆囊切除术与腹腔镜胆囊切除术治疗良性胆囊疾病的初步比较结果:回顾性单中心、单术者分析

阅读:1

Abstract

INTRODUCTION: This study aimed to compare the outcomes of Versius Robotic System-assisted cholecystectomy with conventional laparoscopic cholecystectomy for benign gall bladder pathologies, focusing on the perioperative and post-operative parameters. PATIENTS AND METHODS: A retrospective study was conducted on patients with Versius Robotic System-assisted (Group VRS) or conventional laparoscopic cholecystectomy (Group LAP) between September 2021 and June 2023. Patient demographics, perioperative (operative time, conversion and intraoperative complications) details, post-operative pain management and complications were analysed. RESULTS: The study included 44 and 58 patients in Groups VRS and LAP. In Group VRS, we detected significantly reduced post-operative pain ( P = 0.009), lower opioid use ( P = 0.009) and shorter hospital stays ( P = 0.029) than in Group LAP. Total operative time was longer in Group VRS ( P < 0.001). No intraoperative complications or conversions occurred in either group. CONCLUSION: Versius Robotic System-assisted cholecystectomy is a safe and feasible approach for benign gall bladder pathologies, offering benefits such as reduced post-operative pain and shorter hospital stays.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。